NCI Breaks Ground on Facility Aimed at Partnership Initiative | GenomeWeb

NEW YORK (GenomeWeb News) – With construction finally starting on the $200 million first phase of the National Cancer Institute's Advanced Technology Research Facility at Riverside Research Park in Frederick, Md. — work delayed because of the recession — the project's locally-based developer has already begun talking to tenant prospects considering leases for the second phase.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.